The Eisenberg Emerging Scholar received NIH’s coveted Mentored Research Scientist Career Development Award, furthering her work to better understand the mechanisms of diabetic neuropathy.
Eva Feldman, M.D., Ph.D., James W. Albers Distinguished University Professor of Neurology, was part of a research group that published insights into the role gender plays in the everyday experiences of women clinician scientists and the related barriers they face.
Stephanie Eid, Ph.D., led a research team that examined gene expression at two different injury sites in peripheral neuropathy to identify new therapy targets, publishing their findings in Translational Research .
Featured on the cover and in a subsequent story of the American Academy of Neurology's Neurology Today , Dr. Eva Feldman explored the environmental triggers of neurodegenerative disease.
Michigan Medicine's Health Lab covered new research about how residential exposure to toxins is associated with ALS risk.
The University of Michigan's independent, student-run newspaper covered the latest research happening at the ALS Center of Excellence.
Recently published research by Dr. Brian Callaghan looking at whether influenza or COVID had a higher neurological burden was covered by U.S. News & World Report, Daily Mail , Science Magazine, Drugs.com and many more.
Kevin Chen M.D., and Stephanie Eid, Ph.D., have been named the inaugural Frances and Kenneth Eisenberg Emerging Scholars at the NeuroNetwork for Emerging Therapies.
The Zambia Cohort of Healthy Aging and Dementia Study (Z-CHAD) was launched by Andrea and Lawrence A. Wolfe Research Professor Melissa Elafros, M.D., Ph.D., to understand the true impact of dementia on patients in Zambia and their caregivers.
Brian Callaghan, M.D., M.S., authored research published in Neurology , the official journal of the American Academy of Neurology, that answered just that.
The Center to Accelerate Population Research in Alzheimer's (CAPRA) featured Andrea and Lawrence A. Wolfe Research Professor Melissa Elafros, M.D., Ph.D., in the CAPRA Quarterly Winter 2024 edition.
Pranger ALS Clinic Director Stephen Goutman, M.D., M.S., was interviewed by the Canadian media organization about this recent publication on ALS recreational risk.
Recent research by Drs. Stephen Goutman and Eva Feldman showed that certain activities, such as golfing and gardening, may represent modifiable risk factors for ALS.
In the journal Academic Medicine, Eva Feldman, M.D., Ph.D., was an author of the study “The Disproportionate Effects of the COVID-19 Pandemic on the Time Allocation of Recipients of NIH Career Development Awards Who Are Women or Caregivers of Dependents.”
Michigan Medicine's Health Lab covered recent research that showed that certain activities such as golfing and gardening may represent modifiable risk factors for ALS.
For International Women's Day this year, we highlight our incredible female collaborators from around the world.
National Geographic interviewed Eva Feldman, M.D., Ph.D., for a story about a new mouse study that shows popular weight loss drugs could lower inflammation and what this means for the treatment of neurodegenerative diseases.
A research team at the NeuroNetwork for Emerging Therapies wrote a seminal review about the “Role of the Exposome in Neurodegenerative Disease,” which was published in Annals of Neurology , the official journal of the American Neurological Association (ANA).
In the area of autoimmune and nerve disorders, people usually think of CIDP (chronic inflammatory demyelinating polyradiculoneuropathy) or Guillain-Barre syndrome. However, there is another autoimmune neuropathy that often goes undiagnosed or mischaracterized as CIDP, called Anti-MAG (myelin-associated-glycoprotein) neuropathy.
Eva Feldman, M.D., Ph.D., was part of a multi-institutional group of authors who published a research article entitled "Gender Differences in Faculty Perceptions of Mentorship and Sponsorship," in JAMA Open Network Open .
